Senior Director, Pipeline Market Access Strategy - Oncology at AbbVie · LumiJobs

Responsibilities

Pipeline Access Strategy & Portfolio Leadership
Owns the end-to-end pipeline Integrated access strategy for all pre-launch and development-stage assets within the assigned Business Unit, ensuring strategies are comprehensive in addressing evidence needs, policy considerations, pricing potential, and commercial considerations. IASs integrate global needs and dynamics through regulatory submission.
Serves as the primary voice of pipeline market access strategies at Business Unit governance forums, including LMG, TASC, CSM, ASTs , and other senior leadership reviews — communicating access risk, opportunity, and strategic direction with clarity and conviction.
Serves as the voice of access into pipeline Business Development opportunities.
Leads prioritization exercises across the pipeline portfolio to ensure resources and strategic attention are allocated to assets with the greatest near- and long-term access complexity and business impact.
Creates and optimizes launch strategies inclusive of considerations for IRA, MFN, and other market forces (US Channel dynamics) to position the asset for sequencing strategies across indications as well as geographies incorporating the pressures
Defines and delivers the Access Roadmap— a cross-functionally developed strategy that articulates the access approach for each pipeline asset by development phase, anticipated launch timing, and global evidence deliverables.
Early Development Integration
Partners with R&D and Regulatory teams to embed access-relevant endpoints, comparators, and trial design elements into clinical development programs from Phase I/II onward — ensuring studies are powered to meet payer and HTA evidence standards at launch and partners with the affiliates.
Defines and champions Target Product Profiles (TPPs) from a market access perspective, translating payer value requirements into actionable clinical and evidence generation guidance for asset teams.
Generates and maintains global payer and HTA evidence requirements across major markets (US, EU5, Japan, and emerging markets), ensuring development programs proactively address the evidence gaps that govern access and reimbursement decisions.
US & International Strategy Alignment

Senior Director, Pipeline Market Access Strategy - Oncology

Responsibilities

Benefits

Company

AbbVie

More roles at AbbVie